GENERIAN PHARMACEUTICALS
Generian team has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks linked to quality control and metabolism. Activation of these validated networks represents a unique approach with applicability across a broad range of chronic diseases. Led by top researchers in the fields of aging, small molecule drug development, and E3 ubiquitin ligase biology, Generian's platform will transform how we treat a wide array of both rare and common conditions using small molecules to reset and restore cellular homeostasis.
GENERIAN PHARMACEUTICALS
Social Links:
Industry:
Health Care Pharmaceutical
Founded:
2019-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.generian.com
Total Employee:
1+
Status:
Active
Contact:
412-770-1621
Total Funding:
12.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Founder
Official Site Inspections
http://www.generian.com Semrush global rank: 7.79 M Semrush visits lastest month: 437
- Host name: 14.52.105.34.bc.googleusercontent.com
- IP address: 34.105.52.14
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Generian Pharmaceuticals"
About Us - Generian
David is the Head of Chemistry at Generian and has over 40 years of experience in the pharmaceutical industry. He spent 25 years at Squibb/Bristol-Myers Squibb (BMS) where he …See details»
Generian: Thinking big about small molecule therapeutics
Jun 29, 2022 Pittsburgh, PA and Cambridge, MA, February 8, 2023 – Generian Pharmaceuticals, Inc., a preclinical biopharmaceutical company discovering and developing first-in-class orally bioavailable small molecule therapeutics, …See details»
Generian Pharmaceuticals - Crunchbase Company Profile & Funding
Generian team has developed an innovative approach to uncover first-in-class, gain-of-function drugs that activate key cellular networks linked to quality control and metabolism. Activation of …See details»
Generian Pharmaceuticals - Overview, News & Similar companies ...
Who is Generian Pharmaceuticals. Generian Pharmaceuticals is a preclinical biotechnology company focused on developing novel, orally available small molecule therapeutics for disea …See details»
Generian | LinkedIn
Generian is building a first-in-class drug discovery pipeline of small molecule drugs to address the shortcomings of biologics and improve the patient experience by increasing convenience and access.See details»
Generian Pharmaceuticals - PitchBook
Generian Pharmaceuticals General Information Description. Developer of a gain-of-function medicines intended to activate coordinated cellular networks. The company's medicines activate cellular networks linked to quality control and …See details»
Generian Company Profile - Office Locations, Competitors ... - Craft
Generian Pharmaceuticals is a developer of gain-of-function medicines that activate coordinated cellular networks linked to quality control and metabolism. Its medicines aim to increase …See details»
Generian Pharmaceuticals - Contacts, Employees, Board Members, …
Generian Pharmaceuticals has 5 current employee profiles, including Co-Founder Yuan Liu. Yuan Liu Co-Founder Toren Finkel Chief Scientific Officer & Co-FounderSee details»
Generian Pharmaceuticals - Funding, Financials, Valuation
Generian Pharmaceuticals has raised a total of . obfuscated. obfuscated. in funding over 1 round. This was a Venture - Series Unknown round raised on Oct 1, 2019. ... How much funding has …See details»
Generian Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Generian Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 8 news, Disease Domain:Endocrinology and Metabolic Disease, …See details»
Generian and Astellas Enter into Collaboration and …
Jun 29, 2022 Generian Pharmaceuticals, which was formed by UPMC Enterprises, the innovation, commercialization and venture capital arm of UPMC, is a private biotechnology company that is focused on developing ...See details»
Generian Pharmaceuticals - VentureRadar
Generian is advancing a valuable pipeline of first-in-class drug candidates that therapeutically modulate target protein structure and/or dynamics resulting in functional inhibition or …See details»
Generian and Astellas Enter into Collaboration and Exclusive …
Jun 29, 2022 Pittsburgh, PA and Cambridge, MA, June 29, 2022 – Generian Pharmaceuticals, Inc. (“Generian”) and Mitobridge, Inc. (a wholly owned subsidiary of Astellas Pharma Inc.) …See details»
Generian Pharmaceuticals - Products, Competitors, Financials, …
Generian Pharmaceuticals focuses on developing small-molecule therapeutics designed to overcome biologics' limitations and enhance patient accessibility and convenience. The …See details»
Targeted protein drug firms advance | C&EN Global Enterprise
Jul 4, 2022 Generian Pharmaceuticals and Mitobridge, a subsidiary of Astellas Pharma, have formed a partnership to identify and develop small molecules that modulate undruggable …See details»
Hank Safferstein, PhD, JD, MBA | UPMC Enterprises
Hank Safferstein, PhD, JD, MBA, currently serves as a Senior Advisor, UPMC Enterprises and CEO, Generian, a UPMC portfolio company. He is Board Director of Ariel Precision Medicine. …See details»
Generian, Astellas to develop molecules for undruggable therapeutic
As per the terms of the agreement, Generian will receive an upfront payment and is eligible for milestone payments of more than $180m as well as the single digit royalties depending on the …See details»
Generian Achieves First Milestones in Mitobridge Collaboration
Feb 8, 2023 Generian Contact: Investor and Media inquiries Argot Partners [email protected] Astellas Contact: Astellas Pharma Inc. Corporate Advocacy & Relations +81-3-3244-3201. …See details»
The Approach - Generian
The Approach We believe our approach of combining the mechanistic certainty of target-based discovery with the richness and power of disease-relevant phenotypic assays represents a …See details»
Pipeline and Targets - Generian
Our Pipeline . We strive to discover and develop small molecule therapeutics for diseases with high unmet need—specifically areas dominated by biologics.See details»